Kathryn E. Crosier
Papers
2
Total Citations
39
H-Index
2
About
Kathryn E. Crosier is a pioneering researcher in developmental biology and toxicology, with a specialized focus on transgenic zebrafish models and microfluidic technologies. Her major contributions lie in the development of integrated chip-based platforms that enable automated, high-throughput analysis of zebrafish embryos for pharmaceutical screening and ecotoxicology. Her most-cited work, the "Integrated chip‐based physiometer for automated fish embryo toxicity biotests" (2014, 32 citations), introduced a revolutionary system for immobilizing and treating large numbers of spatially encoded embryos, significantly advancing drug discovery and molecular pathology. Crosier further expanded this approach in her study on "Dynamic analysis of angiogenesis in transgenic zebrafish embryos using a 3D multilayer chip-based technology" (2013, 7 citations), which provided unprecedented insights into vascular development. By combining transgenic zebrafish models with microfluidic innovation, she has created powerful tools for real-time, non-invasive observation of disease processes and toxicological responses. Her work is particularly notable for bridging the gap between traditional animal models and modern automation, offering scalable solutions for both basic research and regulatory toxicology. Crosier’s contributions continue to influence the fields of developmental biology, environmental health, and pharmaceutical science.
Research Focus
Key Achievements
Top Papers
- 1
- 2